Predicting the Risk of Developing Cancer from Common Blood Disorder - News CenterA new method helps predict cancer risk from a common blood disorder in older adults, potentially guiding early intervention.
Combination Therapy Improves Outcomes for Rare Blood Disorder - News CenterCombination treatment of danicopan with C5 inhibitors shows promise in improving anemia in PNH patients resistant to previous therapies.
CRISPR genome-editing grows up: advanced therapies head for the clinicGene-editing therapies like Casgevy show long-lasting benefits for blood disorders but face challenges in accessibility due to complexity and cost.